Drug details

Emcyt (estramustine)

type of Antineoplastics Hormones

Emcyt (estramustine phosphate sodium) is an antineoplastic (anti-cancer) drug used to treat prostate cancer.

The drug is often used to treat Prostate cancer .

This drug may have the following side effects:
  • hives,
  • difficulty breathing,
  • swelling of your face, lips, tongue, or throat,
  • nausea,
  • shortness of breath,
  • rapid breathing,
  • chest pain,
  • pain spreading to your jaw or shoulder,
  • severe headache,
  • swelling,
  • wheezing,
  • sweating,
  • chest pain or pressure,
  • sudden cough,
  • rapid weight gain,
  • sudden numbness or weakness (especially on one side of the body),
  • slurred speech,
  • coughing up blood,
  • balance problems,
  • warmth, and
  • redness in an arm or leg
The following drugs are related to Emcyt, either as a replacement or used together:
  • Zytiga (abiraterone acetate tablets)
  • Jevtana (cabazitaxel injection)
  • Eligard (leuprolide acetate)
  • Zoladex 3.6 (goserelin acetate implant)
  • Vantas (histrelin acetate)
  • Lupron Depot 11.25 mg (leuprolide acetate for depot suspension)
  • Lupron Depot 22.5 (leuprolide acetate for depot suspension injection)
  • Viadur (leuprolide acetate implant)
  • Lupron (leuprolide acetate injection)
  • Pluvicto (lutetium lu 177 vipivotide tetraxetan)
  • Provenge (sipuleucel-t suspension for intravenous infusion)
  • Xofigo (radium ra 223 dichloride)
  • Trelstar (triptorelin pamoate for injectable suspension)
  • Trelstar Depot (triptorelin pamoate for injectable suspension)
  • Trelstar LA (triptorelin pamoate for injectable suspension)
  • Zometa (zoledronic acid for inj)
The following supplements are related to Emcyt, and may be used together with the drug:
  • Selenium (s.)
  • Strontium (s.)